Cargando…

A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results

BACKGROUND: Regorafenib is one of several FDA‐approved cancer therapies targeting multiple tyrosine kinases. However, there are few subtype‐specific data regarding kinase inhibitor activity in sarcomas. We report results of a single arm, phase II trial of regorafenib in advanced Ewing family sarcoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Attia, Steven, Bolejack, Vanessa, Ganjoo, Kristen N., George, Suzanne, Agulnik, Mark, Rushing, Daniel, Loggers, Elizabeth T., Livingston, Michael B., Wright, Jennifer, Chawla, Sant P., Okuno, Scott H., Reinke, Denise K., Riedel, Richard F., Davis, Lara E., Ryan, Christopher W., Maki, Robert G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883574/ https://www.ncbi.nlm.nih.gov/pubmed/35950293 http://dx.doi.org/10.1002/cam4.5044

Ejemplares similares

A Randomized, Double‐Blind, Placebo‐Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Study
por: Riedel, Richard F., et al.
Publicado: (2020)

Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)
por: Kim, AeRang, et al.
Publicado: (2020)

SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors
por: Higham, Christine S., et al.
Publicado: (2017)

Letrozole in the neoadjuvant setting: the P024 trial
por: Ellis, Matthew J., et al.
Publicado: (2007)

Letrozole in the neoadjuvant setting the P024 trial
por: Ellis, Matthew J., et al.
Publicado: (2007)

SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma
por: Chugh, Rashmi, et al.
Publicado: (2020)

Sinonasal FUS-ERG-Rearranged Ewing's Sarcoma Mimicking Glomangiopericytoma
por: Zhou, Maggie, et al.
Publicado: (2020)

The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma
por: Heater, Natalie K., et al.
Publicado: (2023)

The usefulness of SARC-F
por: Piotrowicz, Karolina, et al.
Publicado: (2021)

Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial
por: Ellis, Matthew J., et al.
Publicado: (2008)

Comparison of Diagnostic Performance of SARC-F and Its Two Modified Versions (SARC-CalF and SARC-F+EBM) in Community-Dwelling Older Adults from Poland
por: Krzymińska-Siemaszko, Roma, et al.
Publicado: (2020)

Comparing SARC-CalF With SARC-F for Screening Sarcopenia in Adults With Type 2 Diabetes Mellitus
por: Xu, Zeru, et al.
Publicado: (2022)

Diagnostic performance of calf circumference, SARC-F, and SARC-CalF for possible sarcopenia screening in Indonesia
por: Kandinata, Stefanus G., et al.
Publicado: (2023)

Diagnostic performance of SARC-F and SARC-CalF in screening for sarcopenia in older adults in Northern Brazil
por: Barreto de Lima, Alex, et al.
Publicado: (2023)

Clinical Activity of Pazopanib in Metastatic Extraosseous Ewing Sarcoma
por: Attia, Steven, et al.
Publicado: (2015)

Sarcopenia for predicting mortality among elderly nursing home residents: SARC-F versus SARC-CalF
por: Yang, Ming, et al.
Publicado: (2019)

Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma
por: Ghisoli, Maurizio, et al.
Publicado: (2015)

Bioinformatic Analysis of Recurrent Genomic Alterations and Corresponding Pathway Alterations in Ewing Sarcoma
por: Rock, Adam, et al.
Publicado: (2023)

Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial
por: Jones, Robin L., et al.
Publicado: (2022)

Identification of Probable sarcopenia based on SARC-F and SARC-CalF in older adults from a low-resource setting
por: Vidal-Cuellar, Claudia L., et al.
Publicado: (2022)

SARC-F and SARC-CalF Scores as Mortality Risk Factors in Older Men with Cancer: A Longitudinal Study from Peru
por: Ururi-Cupi, K., et al.
Publicado: (2022)

Evaluation of SARC-F and SARC-CalF for sarcopenia screening in patients with chronic musculoskeletal pain: A prospective cross-sectional study
por: Tsuji, Hironori, et al.
Publicado: (2022)

Comparison of SARC-F Score among Gastrointestinal Diseases
por: Ushiro, Kosuke, et al.
Publicado: (2021)

Accurate SARC-F Score in Patients with Liver Disease
por: Matsui, Masahiro, et al.
Publicado: (2023)

Workshop report on the 2(nd) Joint ENCCA/EuroSARC European bone sarcoma network meeting: integration of clinical trials with tumour biology
por: Anninga, Jakob K, et al.
Publicado: (2014)

Prevalence of sarcopenia in pre-frail community dwelling older adult and utility of SARC-F, SARC-CalF and calf circumference in case finding
por: Lim, Jia Yi, et al.
Publicado: (2020)

Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer
por: Karasic, Thomas B, et al.
Publicado: (2022)

A multicenter phase II study of Q3 week or weekly paclitaxel in combination with bevacizumab for the treatment of metastatic or unresectable angiosarcoma
por: Bui, Nam, et al.
Publicado: (2018)

A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)
por: Clarke, Jeffrey Melson, et al.
Publicado: (2019)

Salbutamol for analgesia in renal colic: study protocol for a prospective, randomised, placebo-controlled phase II trial (SARC)
por: Johnson, Graham, et al.
Publicado: (2022)

CMS ARDA Meeting, ARDA-Note-2004-024
por: CERN. Geneva
Publicado: (2004)

Polish Translation and Validation of the SARC-F Tool for the Assessment of Sarcopenia
por: Zasadzka, Ewa, et al.
Publicado: (2020)

Association of SARC-F Questionnaire and Mortality in Prevalent Hemodialysis Patients
por: Lin, Yu-Li, et al.
Publicado: (2020)

Identifying Patients with Osteoarthritis at Risk of Sarcopenia using the SARC-F
por: Lovett, Maggie, et al.
Publicado: (2021)

Prognostic Impact of the SARC-F Score in Gastrointestinal Advanced Cancers
por: Matsui, Masahiro, et al.
Publicado: (2021)

Sarcopenic Obesity in Individuals With Neurodisabilities: The SarcObeNDS Study
por: Dionyssiotis, Yannis, et al.
Publicado: (2022)

Use of the SARC-F Score as an Aid in Fragility Fractures Prevention
por: Martini, Carlos Augusto Nunes, et al.
Publicado: (2022)

A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies
por: How, Joan, et al.
Publicado: (2022)

Ewing's Sarcoma as a Second Malignancy in Long-Term Survivors of Childhood Hematologic Malignancies
por: Wolpert, Fabian, et al.
Publicado: (2016)

Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma
por: Shulman, David S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qn5hpref8q2t8jabgmj5ie35an